Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 158
  • Start Date: July 6, 2021
A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Investigate the Efficacy and Safety of Mexiletine During 26 Weeks of Treatment in Patients With Myotonic Dystrophy Type 1 and Type 2 [The MIND Study]
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 56
  • Start Date: February 2021
A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Tideglusib Versus Placebo for the Treatment of Children and Adolescents With Congenital Myotonic Dystrophy (REACH CDM)
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Radiation, Other
  • Participants: 150
  • Start Date: January 2021
Links Between Diabetes and Cognitive Impairment in Myotonic Dystrophy Type 1 : a Non-conventional MRI Study
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Dietary Supplement
  • Participants: 30
  • Start Date: November 9, 2020
Assessing the Effect of the MYODM Food Supplement on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 22
  • Start Date: October 27, 2020
Poor Neck Proprioception May Cause Balance Deficits in Myotonic Dystrophy 1
Clinical Trial
  • Status: Active, not recruiting
  • Intervention Type: Genetic
  • Participants: 36
  • Start Date: September 1, 2020
Comparison of Two NGS Phasing Techniques of Parental Haplotypes for NIPD of Triplet Expansion Diseases
Clinical Trial
  • Status: Recruiting
  • Participants: 180
  • Start Date: February 24, 2020
Assessing Clinical Endpoint and Biomarkers in Myotonic Dystrophy Type-1 and Type-2
Clinical Trial
  • Status: Active, not recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 13
  • Start Date: December 6, 2019
Functional and Cellular Benefits of Aerobic Exercise in Myotonic Dystrophy Type 1 Patients
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 45
  • Start Date: August 15, 2019
DM-IMT - Controlled, Randomized, Three-arm Intervention Study on the Safety and Efficacy of Regular Respiratory Muscle Training in Patients With Myotonic Dystrophy Type 1
Clinical Trial
  • Status: Enrolling by invitation
  • Participants: 700
  • Start Date: January 1, 2019
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Biological, Genetic
  • Participants: 69
  • Start Date: June 11, 2018
Venous Thromboembolism in Myotonic Dystrophy Type 1
Clinical Trial
  • Status: Recruiting
  • Participants: 20000
  • Start Date: July 2013
A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
Showing 1-12 of 17